DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

107.38 2.13 (2.02%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ALNY $107.38 2.02%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $105.81
Previous Close $105.25
Daily Range $104.88 - $108.42
52-Week Range $71.14 - $140.00
Market Cap $9.1B
P/E Ratio -40.33
Dividend (Yield) $0.00 (0.0%)
Volume 177,969
Average Daily Volume 903,506
Current FY EPS -$3.38




Drug Makers

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website:

News & Commentary

These 3 Biotechs Are Winning in the Clinic

Here's the latest compelling data from Aimmune, Alnylam, and AstraZeneca.

Clinton's Price Caps Are A Non-Starter: Liana Moussatos Of Wedbush Securities

Premarket Biotech Digest: Pfizergan, Gilead's Milestone, MannKind CEO Steps Down

Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis

Weekly Insider Sells Highlights: Facebook, PacWest Bancorp, Waste Management, Alnylam ...

Alnylam Pharmaceuticals, Inc. Earnings: 100% Positive (Data)

Without any sales, the biotech reiterates its positive pipeline record.

These 2 Companies Could Revolutionize Heart Disease Prevention

Early human clinical trial results suggest that a better drug for lowering bad cholesterol may be on the horizon.

Trade-Ideas: Alnylam Pharmaceuticals (ALNY) Is Today's "Dead Cat Bounce" Stock

Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward

Alnylam (ALNY) Reports Positive Interim Data on ALN-PCSsc

See More ALNY News...

ALNY's Top Competitors

ALNY $107.38 (2.02%)
Current stock: ALNY
AMGN $163.52 (-0.26%)
Current stock: AMGN
GILD $108.00 (0.20%)
Current stock: GILD
BIIB $293.21 (0.31%)
Current stock: BIIB